IVF Not Tied to Worse Developmental, Educational Outcomes
Findings for assessments conducted both at 4 to 6 years and 7 to 9 years versus spontaneously conceived children
Diagnosis & Disease Information
CDC Reports on Prevalence of Seasonal and Food Allergies, Eczema
18.9 percent of children and 25.7 percent of adults had seasonal allergy; 10.8 and 7.3 percent had eczema in 2021
Odactra Approved for Adolescents With House Dust Mite Allergic Rhinitis
Odactra is an allergen extract indicated as immunotherapy for the treatment of HDM-induced allergic rhinitis.
USPSTF: Evidence Lacking for Lipid Disorder Screening in Children
Current evidence is inadequate for assessing the balance of benefits and harms of screening in a pediatric population
Emergency Department Preparedness Cuts Mortality Risk in Children
Emergency departments in highest quartile of pediatric readiness had lower in-hospital mortality among injured and medically ill children
Pediatric Cannabis Poisoning Increased With Edible Cannabis Sales
Canadian provinces permitting edible cannabis sales experienced much larger increases in hospitalizations for unintentional poisoning
Respiratory Virus Coinfection May Up SARS-CoV-2 Severity in Children Under 5
For children younger than 5 years, having any viral codetection or rhinovirus/enterovirus codetection significantly linked to severe illness
Cannabis Legalization Tied to Increases in Pediatric Asthma
Increases seen compared with states where neither recreational nor medical legalization has occurred
Vaccine Coverage by Age 24 Months Unchanged During Pandemic
Coverage with combined seven vaccine series decreased for children living below federal poverty level, in rural areas
MPR Weekly Dose Podcast Episode #144
FDA grant accelerated approval to Alzheimer disease treatment; New fixed-dose asthma treatment; NERD therapy looks promising; Leukemia drug to be withdrawn in 2023; Pertussis prevention treatment approved for use during pregnancy.
